Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular ... - World News Media Monitoring -BoardProspects

Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular ...

World News Media Monitoring Mar 8 2017

Acasti Pharma Inc. today announced the appointment of Barry A. Franklin, Ph.D. and Robert Hegele, M.D. to its newly formed Scientific Advisory Board. Drs. Franklin and Hegele will advise Acasti on scientific matters and on the clinical development of CaPre®...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Advent Software Appoints Michael Frandsen to Board of Directors also written by Ipd Group
- Chiquita Shareholders Reject Merger With Irish Company Fyffes also written by Ipd Group
- Lucio Lanza Joins Electronic System Design Alliance Board of Directors also written by Ipd Group
- Six Questions to Answer Before Establishing an Advisory Board By: Susan Hammond also mentions Advisory Boards
- Hong Kong Corporate Governance Excellence Awards 2013 Accepts also written by Ipd Group
- Rubius Therapeutics Appoints Natalie Holles to its Board of Directors also published in World News Media Monitoring
- TransAlta Appoints Mr. Thomas Jenkins to its Board of Directors also written by Ipd Group
- Insulet Appoints Timothy J. Scannell to Board of Directors also written by Ipd Group
- Sigma Designs, Inc. Announces the Appointment of Tor Braham to Its Board of also written by Ipd Group
- Donald Berwick, Md, Mpp, Frcp Joins COTA's Board of Directors also written by Ipd Group

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. Drs. Franklin and Hegele are recognized thought leaders with extensive experience in the cardiovascular space, and they will be valuable additions to the Acasti Scientific Advisory Board.
2. Lifestyle modification, cardioprotective medications and select supplements provide independent and additive benefits in combatting cardiovascular disease.
3. A large portion of my practice involves patients with hypertriglyceridemia, some of whom can be challenging to treat.
Topics Mentioned
- Public Companies
- Advisory Boards
Authors
- Ipd Group